Printer Friendly

U.S. cancer rates continue to fall, but challenges remain.

OVERALL CANCER death rates have continued to drop in the United States in recent years, but rates are rising for melanoma of the skin and for cancers of the liver, pancreas and uterus, according to a recent report.

The report, published online Jan. 7 in the Journal of the National Cancer Institute, includes a special feature on some cancers related to human papillomavirus as well as HPV vaccination coverage levels. That section found increasing rates of HPV-associated oropharyngeal and anal cancers and that vaccination coverage levels in the United States during 2008 and 2010 remained low among girls.

The yearly report found a decline in overall cancer death rates, continuing a trend that started in the early 1990s. From 2000 through 2009, cancer death rates dropped by 1.8 percent per year among men and 1.4 percent per year among women.

The report, which has been produced yearly since 1998, was co-authored by the American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute and the North American Association of Central Cancer Registries. It found that in 2010, fewer than half of girls ages 13-17 had received at least one dose of HPV vaccine, and only 32 percent had received all three doses.

"Far too many girls are growing into adulthood vulnerable to cervical cancer because they are not vaccinated," said CDC Director Thomas Frieden, MD, MPH.

For more information on the report, visit www.cancer.gov.
COPYRIGHT 2013 The Nation's Health
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Currie, Donya
Publication:The Nation's Health
Date:Feb 1, 2013
Words:242
Previous Article:EPA's new air quality standard for fine particles a public health "win".
Next Article:School-based health centers get new grants.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |